Explore 3 Stock Ideas & Industry Insights Download Free Report

Pangenomic Health Inc.

Company price
0.3 CAD 0.00(0%)
Last update at 2026-11-06T14:30:00Z
Market Cap
9.89M

Momentum Score

…

Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness. It also provides MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021. The company was incorporated in 2015 and is based in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.30
Low
0.30
High
52 Week Price Range
0.16
Low
2.57
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Pangenomic Health Inc. (NARA.CN) are limited, and available materials do not clearly document its core products, services or markets, constraining a reliable assessment of long-term growth drivers. Investors may find the stock of interest if the company provides clearer strategic direction, demonstrable commercial traction or regulatory milestones that could support revenue growth.
The most important investment risk is the paucity of verifiable financial and operational information, which increases execution, financing and liquidity uncertainty and heightens regulatory and market-risk exposure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.30
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
-0.75M
Debt / Equity
-
ROE
-4520.62%
Net Debt
0.95M
ROCE
47.91%
Diluted EPS TTM
-0.31

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.80M -2.97M -11.99M -2.65M
Net income -3.80M -2.97M -11.99M -2.65M
Selling general administrative 1.12M 2.46M 3.03M 0.72M
Reconciled depreciation 0.01M 0.01M 0.01M 0.00M
Operating income -1.15M -2.86M -3.64M -0.87M
Interest expense 0.07M 0.04M 0.00M 0.00M
Interest income 0.00M 0.00M 0.00M 0.02M
Net interest income -0.07M -0.04M 0.00M 0.01M
Total revenue 0.00M 0.00M 0.00M 0.00M
Total operating expenses 1.15M 2.86M 3.64M 0.87M
Total other income expense net -2.58M -0.07M -8.35M -1.79M
Net income from continuing ops -3.80M -2.97M -11.99M -2.65M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.04M 0.07M 0.50M 2.58M
Intangible assets - - - 0.85M
Total liab 2.44M 2.22M 0.72M 0.33M
Total stockholder equity -2.41M -2.14M -0.22M 2.24M
Capital stock 14.21M 12.07M 11.24M 5.13M
Retained earnings -21.76M -17.95M -14.98M -2.99M
Cash 0.00M 0.01M 0.09M 1.35M
Total current liabilities 2.44M 2.22M 0.72M 0.33M
Net debt - 0.95M 0.01M -
Short long term debt - 0.96M 0.10M -
Total current assets 0.04M 0.06M 0.48M 1.67M
Net receivables 0.03M 0.04M - -
Accounts payable 1.14M 0.80M 0.37M 0.17M
Non current assets total 0.00M 0.01M 0.02M 0.91M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net borrowings 0.05M 0.96M 0.14M 0.02M
Total cash from financing activities 0.05M 1.50M 1.57M 2.97M
Net income -3.80M -2.97M -11.99M -2.65M
Change in cash -0.01M -0.08M -1.26M 1.31M
Begin period cash flow 0.01M 0.09M 1.35M 0.04M
End period cash flow 0.00M 0.01M 0.09M 1.35M
Total cash from operating activities -0.06M -1.57M -2.78M -1.06M
Issuance of capital stock 0.00M 0.20M 1.29M 2.95M
Depreciation 0.01M 0.01M 0.01M 0.00M
Capital expenditures 0.00M 0.00M 0.01M 0.01M
Change in working capital 1.24M 1.14M 0.23M -0.26M
Stock based compensation -0.14M 0.17M 0.62M 0.05M
Other non cash items 0.07M 0.04M 0.03M 0.00M
Free cash flow -0.06M -1.57M -2.79M -1.07M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
NARA
Pangenomic Health Inc.
-
-%
0.30 - - - 5.38 -0.11
AIDR
Rocket Doctor AI Inc
-0.01
1.06%
0.47 - - 1671.77 6.46 -0.39
DMED
Diagnamed Holdings Corp.
-0.01
14.29%
0.03 - - - 10.74 -1.43
AIML
AI/ML Innovations Inc
-
-%
0.04 - - 70.85 35.17 -3.59
UDOC
UniDoc Health Corp.
0.01
11.11%
0.05 - - 10.64 668.99 -9.56

Profile*

Pangenomic Health Inc.

Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness. It also provides MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021. The company was incorporated in 2015 and is based in Vancouver, Canada.

315 ? 1275 West 6th Avenue, Vancouver, BC, Canada, V6H 1A6

604-218-5788

Name Title Year Born
Mr. Robert Carl Nygren Co-Founder & Executive Chairman 1963
Ms. Maryam Marissen CEO, President & Director NA
Mr. Vincent L. Lum Co-Founder 1961
Ms. Tammy Gillis C.M.A., CPA Treasurer & Secretary 1974
Mr. Derek Ho Director of Operations NA
Mr. Kaidong Zhang Chief Scientific Officer 1978
Mr. Colin Quon Chief Technology Officer of MUJN Diagnostics 1968
Mr. Robert Carl Nygren Co-Founder & Executive Chairman 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…